Sterling Capital Management LLC raised its position in shares of Cardiovascular Systems Inc (NASDAQ:CSII) by 15.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 59,527 shares of the medical device company’s stock after purchasing an additional 8,122 shares during the period. Sterling Capital Management LLC owned 0.17% of Cardiovascular Systems worth $1,676,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in CSII. New York State Common Retirement Fund grew its holdings in Cardiovascular Systems by 346.8% during the second quarter. New York State Common Retirement Fund now owns 443,304 shares of the medical device company’s stock valued at $14,288,000 after purchasing an additional 344,082 shares during the period. Point72 Asset Management L.P. grew its holdings in Cardiovascular Systems by 132.7% during the third quarter. Point72 Asset Management L.P. now owns 469,978 shares of the medical device company’s stock valued at $13,230,000 after purchasing an additional 267,988 shares during the period. Fred Alger Management Inc. bought a new position in Cardiovascular Systems during the second quarter valued at $7,327,000. Vanguard Group Inc. grew its holdings in Cardiovascular Systems by 12.6% during the second quarter. Vanguard Group Inc. now owns 1,864,604 shares of the medical device company’s stock valued at $60,096,000 after purchasing an additional 208,248 shares during the period. Finally, Gabelli Funds LLC boosted its holdings in shares of Cardiovascular Systems by 223.1% in the third quarter. Gabelli Funds LLC now owns 218,500 shares of the medical device company’s stock worth $6,151,000 after acquiring an additional 150,880 shares during the period. 75.05% of the stock is owned by institutional investors and hedge funds.
CSII has been the subject of a number of analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $36.00 price target (down from $37.00) on shares of Cardiovascular Systems in a report on Thursday, October 26th. Raymond James Financial reaffirmed a “hold” rating on shares of Cardiovascular Systems in a report on Monday, December 4th. Zacks Investment Research raised Cardiovascular Systems from a “sell” rating to a “hold” rating in a report on Monday, November 13th. Finally, Citigroup initiated coverage on Cardiovascular Systems in a report on Thursday, September 21st. They issued a “market perform” rating for the company. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. Cardiovascular Systems has an average rating of “Hold” and an average target price of $31.50.
Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, October 25th. The medical device company reported ($0.06) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The firm had revenue of $49.70 million during the quarter, compared to analyst estimates of $51.00 million. During the same period last year, the company earned ($0.06) earnings per share. The business’s revenue for the quarter was down .2% on a year-over-year basis. research analysts anticipate that Cardiovascular Systems Inc will post -0.05 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Sterling Capital Management LLC Increases Holdings in Cardiovascular Systems Inc (CSII)” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://sportsperspectives.com/2017/12/19/sterling-capital-management-llc-increases-holdings-in-cardiovascular-systems-inc-csii.html.
Cardiovascular Systems Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems Inc (NASDAQ:CSII).
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.